老年女性高尿酸血症与冠状动脉病变程度的相关性

目的 探讨老年女性高尿酸血症(Hyperuricemia,HUA)与冠状动脉造影确诊的冠心病的冠脉病变程度的关系.方法 回顾性分析400例老年女性,根据冠状动脉造影结果分为两组,冠心病组260例,非冠心病组即对照组140例,观察两组吸烟、高血压病、2型糖尿病、高脂血症、冠心病家族史、体重指数及高尿酸血症与冠心病发病的关系.再将老年女性按血尿酸浓度>360 μmol/L的标准诊断高尿酸血症分为HUA组与非HUA组,观察HUA与冠脉病变支数及Gensini积分的关系.结果 ①老年女性冠心病组高尿酸血症的比例(23.1%)高于对照组(12.1%),差异有统计学意义(P<0.05).②HUA为老年女性冠心病发生的影响因素(OR=2.171,95%CI:1.223~3.853,Wald χ2=6.99),但对其他指标进行校正采用多因素Logisitic逐步回归进行危险因素筛选,HUA并不是老年女性冠心病发生的独立危险因素.③老年女性病变血管支数的分布在HUA 组与非 HUA组之间差异有统计学意义(Z=2.78,P<0.05).老年女性HUA患者的Gensini 积分高于非HUA患者(Z=2.08 P<0.05),且在女性的全组、HUA 组及非HUA 组Gensini 积分与血尿酸水平均呈正相关(rs =0.177,0.213,0.152,P<0.05).结论 老年女性HUA与冠心病发生有一定关联,但不是独立危险因素,HUA是反应冠心病病情程度的一个重要指标.老年女性高尿酸血症患者在冠心病诊治上应引起重视.     

高尿酸血症与冠脉造影确诊的冠心病的相关性

目的:探讨高尿酸血症(HUA)与冠脉造影确诊的冠心病(CAD)的发生及严重程度的相关性。方法:对647例接受冠脉造影的患者测定各项临床指标,根据冠脉造影结果分为CAD组和对照组,以发生病变的血管支数及Gen?sini积分反映冠心病严重程度,分性别进行对照研究。结果:(1)女性CAD组的HUA比例高于对照组(P=0.012)。(2)HUA仅在女性是冠心病发生的影响因素(OR=2.022,95%CI:1.098~3.723,P=0.023),但在对年龄进行调整后,HUA亦未入选冠心病影响因素(OR=1.513,95%CI:0.778~2.931,P=0.221)。两性患有HUA都不是冠心病发生的独立危险因素。(3)女性病变血管支数的分布在HUA组与非HUA组之间差异有统计学意义(Z=2.51,P=0.01)。女性HUA患者的Gensini积分高于非HUA患者(P=0.04),且在女性的全组、HUA组及非HUA组Gensini积分与血尿酸水平均呈正相关(rs分别为0.181、0.291和0.138,P<0.05或P<0.01)。结论:女性HUA与冠心病的发生有一定关联,但不是独立危险因素。临床诊断中似应重视高龄女性HUA患者发生冠心病的危险。     

血清尿酸水平与冠状动脉病变程度的关系

目的:探讨冠状动脉造影患者血清尿酸(SUA)水平与冠状动脉病变程度的关系.方法:入选我院行冠状动脉造影(CAG)患者474例,根据CAG结果分为冠心病(CAD)组(366例)和非CAD组(108例).冠状动脉病变程度采用冠状动脉病变支数和冠状动脉病变Gensini积分(GS)量化.结果:(1)总体CAD组SUA水平高于非CAD组(P<0.05),亚组分析女性CAD组SUA水平高于女性非CAD组(P<0.05);总体CAD组、男性CAD组、女性CAD组高尿酸(HUA)百分比均高于非CAD组(P<0.05).(2)SUA水平第3、第4四分位的CAD患病率明显高于第1、第2四分位(P<0.05).(3)多因素Logistic回归分析显示HUA是经CAG诊断的CAD的危险因素(OR=2.639,95%CI为1.080～6.443,P=0.033).(4)相关分析提示SUA水平和GS有正相关性(r=0.270,P<0.01),亚组分析男性、女性SUA水平和GS间均有正相关性(r=0.171,P<0.01;r=0.298,P<0.01).结论:SUA可能是CAG诊断的CAD的危险因素.SUA水平和冠状动脉病变程度有一定相关性,女性相关性较男性略显著.     

高尿酸血症与冠心病患者性别关系的研究

目的 探讨高尿酸血症与冠心病患者性别的关系.方法 选取2012年3-9月于安贞医院急诊综合病房住院患者75例.将40例冠心病患者按性别分为男性冠心病组和女性冠心病组,各20例;同期入组的对照组为经冠状动脉造影证实冠状动脉正常的疑似冠心病患者,男20例,女15例,回顾性收集入选受试者的资料,比较2组患者的年龄、血尿酸、空腹血糖、血肌酐、血脂的情况.结果 男、女冠心病组的平均血尿酸水平未达到高尿酸血症的标准[(351±67)μmol/L、(310 ±74) μmol/L],男性冠心病组尿酸水平高于女性冠心病组(P＜0.05).男性冠心病组尿酸水平与男性对照组[(327±82)μmol/L]比较差异无统计学意义(P＞0.05).女性冠心病组尿酸水平显著高于女性对照组[(216 ±52) μmol/L],差异有统计学意义(P＜0.01).女性冠心病组的HDL-C[(1.09±0.19) mmol/L]低于女性对照组[(1.27±0.23) mmol/L](P＜0.05),而TG[(1.6±0.6)mmol/L]高于女性对照组[(1.1 ±0.4)mmol/L](P＜0.05).结论 高尿酸血症可能是女性冠心病患者的一个危险因素.     

早发急性冠脉综合征患者的临床特点和预后分析

目的 探讨早发急性冠脉综合征(PACS)患者的危险因素、冠脉病变特点和预后情况。方法 选取经冠状动脉造影(CAG)术确诊的急性冠脉综合征(ACS)患者132例,根据年龄分为两组,男性年龄≤55岁、女性年龄≤65岁者60例作为PACS组,而男性年龄＞55岁、女性年龄＞65岁者72例为对照组。统计两组人群基本临床资料,比较其冠脉病变特点和预后情况,并采用多因素logistic回归分析PACS的危险因素。结果(1)PACS组有较明确的发病诱因,其男性比例、吸烟率、早发冠心病(PCHD)家族史、肥胖比例以及低密度脂蛋白胆固醇(LDL-C)水平均高于对照组(P＜0.05),而对照组患者高血压、糖尿病比例明显高于PACS组(P＜0.05);(2)PACS组冠状动脉病变支数、Gensini积分与对照组比较有明显差异(P＜0.05),两组罪犯血管分布差异无统计学意义(P＞0.05);CAG术还发现PACS组以冠脉单支病变和局限性病变为主(P＜0.05)。(3)多因素Logistic回归分析显示,男性、吸烟、PCHD家族史比例以及LDL-C水平是PACS的独立危险因素;(4)院外随访6个月,PACS组的主要心血管不良事件(MACE)发生率明显低于对照组(P＜0.05)。结论 男性、吸烟、PCHD家族史及LDL-C是PACS患者的主要危险因素,改变不良生活方式、控制体重对PACS的发病及预后具有重要的意义。     

对140例女性心电图及冠脉造影特点与冠状动脉病变的探讨

目的 探讨女性冠心病的心电图及冠脉造影特点.方法 对140例临床诊断为冠心病和疑为冠心病女性患者的心电图及冠脉造影结果进行分析,并与同期检查的男性患者270例对比.结果女性心电图阳性率74.2%,男性阳性率54.1%;女性T波改变(45.5%)明显高于男性(31.9%);女性冠脉造影阳性率54.3%,男性冠脉造影阳性率68.9%;二者对比差异具有统计学意义(P＜0.05).女性冠脉病变以单支病变为主,其次为三支、双支病变,病变部位以左前降支为主,其次为左回旋支、右冠脉、左主干.冠脉重度狭窄明显低于男性(P＜0.05).结论 女性心电图阳性率高,T波改变多见;冠脉造影阳性率低,冠脉病变受累支数低于男性,重度狭窄明显低于男性(P＜0.05).冠脉造影对女性冠心病的诊断有重要价值,但亦可能造成女性冠心病漏诊.     

青年男性急性心肌梗死危险因素和冠状动脉造影特征

目的 探讨青年男性急性心肌梗死(AMI)发病危险因素及冠状动脉(冠脉)病变特点.方法 回顾性分析247例AMI男性患者临床资料.其中,青年(年龄21-44岁)患者88例(A组),中年(年龄45-59岁)患者159例(B组),分析两组AMI相关发病危险因素及冠脉病变年龄差异.结果 A组早发冠心病家族史、超重、不良生活方式患者比例及血清总胆固醇(TC)和低密度脂蛋白(LDL)水平均高于B组(P＜0.05).A组单支病变、冠脉Gensini总积分＜4分者多于B组,而多支病变者、冠脉Gensini总积分、罪犯血管Gensini积分少于B组(P＜0.05).结论 早发冠心病家族史、超重、不良生活习惯及高TC和LDL水平为青年早发AMI的关键因素,其中不良生活习惯为最重要因素.     

潍坊社区65岁以上老年人高尿酸血症患病率及影响因素分析

目的:调查本社区65岁以上老年人高尿酸血症(HUA)的患病情况,并对其相关危险因素进行分析.方法:选择2015年4-10月在本社区进行体检的2 433例65岁以上老年人,进行问卷调查、体格检查及实验室检查.根据血尿酸水平分为HUA组290例和正常尿酸组2 143例,采用非条件Logistics回归分析HUA的影响因素.结果:2 433例受检者中,HUA患病率为11.92％,男性和女性患病率分别为18.58％和6.77％ (P=0.000),HUA组男性比例、平均年龄、高血压患者比例、BMI、血肌酐、尿素、Y-谷氨酰转肽酶、总蛋白、白蛋白、TG水平均较正常尿酸组升高,而HDL水平较正常尿酸组明显下降(P＜0.05),多因素Logistics回归分析显示超重、肾功能下降、γ-谷氨酰转肽酶升高、白蛋白升高、高TG血症为HUA的危险因素(P＜0.05).结论:该社区65岁以上老年人HUA患病率相对不高,超重、肾功能下降、高TG血症可能是发生HUA的危险因素,应采取相应措施进行预防.     

高脂血症合并高尿酸血症与冠心病的相关性研究

目的：高脂血症合并高尿酸血症与冠心病风险的相关性。方法选取406例疑诊冠心病患者,根据高脂血症和高尿酸血症的发病情况分为单纯高脂血症组（ n ＝57）、单纯高尿酸血症组（ n ＝94）、高脂血症合并高尿酸血症组（ n ＝110）、无高脂血症和高尿酸组（ n ＝145）。所有患者根据冠状动脉造影检查结果分为冠心病组（ n ＝289）和非冠心病组（ n ＝117）,评估冠状动脉病变程度,分析高脂血症合并高尿酸血症和冠心病之间的关系。结果冠心病组患者的高脂血症和高尿酸血症患病率显著高于非冠心病组,同时冠心病组的血尿酸水平明显高于非冠心病组,差异均有统计学意义（ P ＜0．05）。 Logistic回归结果提示,高脂血症和高尿酸血症是冠心病的危险因素,两者存在交互作用,OR值＞1。高脂血症合并高尿酸血症冠心病患者的冠脉Gensini评分显著升高,高脂血症合并高尿酸血症发病率和冠状动脉病变血管支数存在趋势性增高。结论高尿酸血症是冠心病的独立风险因素的可能性较大,关注患者血清尿酸水平、高脂血症和高尿酸血症的发病情况,利于评估冠心病风险。     

血尿酸水平与冠心病及其严重程度的关系研究

目的:研究血尿酸(UA)水平与冠心病(CAD)的发生及其严重程度的关系.方法:根据冠状动脉造影结果将患者251例分为CAD组148例和非CAD组103例,以发生病变的血管支数反映冠心病严重程度,将患者分为A、B、C、D4组,分别对应冠状动脉正常、1支、2支、3支病变,比较各组间尿酸水平.根据尿酸水平按四分位数将患者分为第1～4组.结果:(1)CAD组血尿酸水平高于非CAD组(P＜0.01),Logistic多因素同归分析显示年龄、天冬氨酸转氨酶、尿酸水平为冠心病的危险因素.(2)尿酸水平与冠脉病变支数呈正相关(rn=0.229,P＜0.01),其中女性组尿酸水平与冠脉病变支数呈正相关(rn=0.317,P＜ 0.01),而男性组无此相关性(rs=-0.36,P=0.671).(3)血尿酸水平第3、第4四分位的CAD患病率明显高于第1、第2四分位(P＜0.01).结论:血清尿酸水平与冠心病的患病率有关,且与冠状动脉病变程度呈正相关.     

左冠状动脉主干狭窄的临床分析

目的探讨左主干狭窄的临床特点和治疗方法.方法分析左主干病变(狭窄≥50%)者和非左主干病变者临床资料.结果1 275例确诊的冠心病患者中,左主干狭窄74例(5.8%),非左主干病变180例(14.1%).左主干合并3支病变占66.2%,左主干病变组心绞痛发生率较非左主干病变组高.57例(77.0%)胸痛发作时心电图ST段下移≥0.2 mV.左主干并3支组与单纯左主干组比较心肌梗死发生率高(P＜0.05),左室射血分数低(P＜0.01).23例行CABG 1年内心绞痛症状消失或明显减轻,3例行无保护左主干直接支架术,术后半年心绞痛明显减轻.结论左主干狭窄者多合并其它冠脉病变,心绞痛严重.冠状动脉旁路移植术是最佳治疗手段.     

宝石能谱CT冠状动脉成像在冠心病诊断中的应用

目的 评价宝石能谱CT冠状动脉成像(CTA)在冠心病诊断中应用价值.方法 63例疑似冠心病分别接受CTA和冠状动脉造影检查,以冠状动脉造影结果为“金标准”对照,评估冠状动脉CTA检查的准确度.结果 冠状动脉CTA可以清晰显示冠状动脉狭窄病变,与冠状动脉造影相比,两者的符合率达96.0％.结论 CTA安全、简便和无创伤,对冠状动脉疾病具有较大的诊断价值.     

经皮冠状动脉介入治疗79例临床分析

目的探讨经皮冠状动脉介入治疗的可行性、安全性和成功率。方法选择该院2005年1月~2009年7月经皮股动脉穿刺冠状动脉腔内成形术（PTCA）及支架术79例患者为研究对象。结果A型病变支架术成功率100%（36/36）,B型病变成功率98.9%（88/89）,C型病变成功率95.3%（41/43）。1例分叉、弯曲、偏心性病变和2例慢性闭塞性病变（CTO）因指引导丝不能通过病变致手术失败,总成功率为98.2%。结论经皮冠状动脉介入治疗创伤小,恢复快,安全且成功率高。     

冠心病住院患者冠状动脉介入诊疗依从性的初步研究

目的探讨影响冠心病患者对冠状动脉介入诊疗的依从性的主要因素。方法回顾性分析2008年10月至2009年7月间我科住院的临床诊断为冠心病的505名患者,观察资费来源、冠心病亚型及年龄阶段三个不同因素对住院期间冠状动脉介入诊疗依从性的影响。结果随着年龄的增长,对冠状动脉介入的依从性逐步减低;军队医保组与自费组较社会医保组依从性较高;疾病类型对介入依从性影响则相对较小。结论在当前医疗保障体制下,心脏冠状动脉介入诊疗的依从性明显受到包括医疗资源保障程度、年龄阶段等多种因素的影响。     

阿托伐他汀干预对急性冠状动脉综合征患者PCI术后粘附分子水平的影响

Objective To explore the impact of different dose atorvastatin on the adhesion molecules level in the acute coronary syndrome (ACS) patients who had received percutaneous coronary intervention (PCI). Methods Eighty-eight ACS patients were divided into three groups, group A (normal treatment group), group B (normal treatment plus atorvastatin 10mg per day) and group C (normal treatment plus atorvastatin 80mg per day). The patients in group B received atorvastatin 10 mg per day orally before PCI and after PCI subsequently, and the patients in group C received atorvastatin 80 mg per day orally before PCI and after PCI subsequently for three days, then the dose of atorvastatin was decrease to 10 mg per day. The concentrations of soluble intercellular adhesionmolecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) were detected before PCI and at the 3rd, 7th 14th day after PCI. Results At the 7th day, the concentrations of sICAM-1 and sVCAM-1 in group C were significantly lower than those in group B, which showed sICAM-1 (68.35±23.80) μg/L vs (131.45±29.12) μg/L and sVCAM-1 (251. 65±36.61)μg/L vs (334.87±32.98) μg/L, respectively. Compared to group A, the adhesion molecule level in group B and group C were significantly decreased (P<0.05) and had no obviously affect on blood fat level. Conclusion The treatment of atorvastatin could significantly decrease the adhesion molecules' level after PCI, which may play an important role in lowing inflammation and coronary artery restenosis after PCI.     

阿托伐他汀干预对急性冠状动脉综合征患者PCI术后粘附分子水平的影响

Objective To explore the impact of different dose atorvastatin on the adhesion molecules level in the acute coronary syndrome (ACS) patients who had received percutaneous coronary intervention (PCI). Methods Eighty-eight ACS patients were divided into three groups, group A (normal treatment group), group B (normal treatment plus atorvastatin 10mg per day) and group C (normal treatment plus atorvastatin 80mg per day). The patients in group B received atorvastatin 10 mg per day orally before PCI and after PCI subsequently, and the patients in group C received atorvastatin 80 mg per day orally before PCI and after PCI subsequently for three days, then the dose of atorvastatin was decrease to 10 mg per day. The concentrations of soluble intercellular adhesionmolecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) were detected before PCI and at the 3rd, 7th 14th day after PCI. Results At the 7th day, the concentrations of sICAM-1 and sVCAM-1 in group C were significantly lower than those in group B, which showed sICAM-1 (68.35±23.80) μg/L vs (131.45±29.12) μg/L and sVCAM-1 (251. 65±36.61)μg/L vs (334.87±32.98) μg/L, respectively. Compared to group A, the adhesion molecule level in group B and group C were significantly decreased (P<0.05) and had no obviously affect on blood fat level. Conclusion The treatment of atorvastatin could significantly decrease the adhesion molecules' level after PCI, which may play an important role in lowing inflammation and coronary artery restenosis after PCI.     

声学密度定量技术与冠状动脉造影术的对比研究

目的：探讨声学密度定量（AD）技术评价正常、狭窄及闭塞血管支配区域心肌的组织特征。方法：对疑诊冠心病的64例患者，根据冠状动脉造影结果将192支冠状动脉分组：正常组（A组）、狭窄组（B组）、闭塞组（C组），检测其相应血管支配区域心肌的背向散射积分参数。结果：与A组相比，B组心肌的背向散射积分的标化值（IBS％）增高；而背向散射积分周期变化幅度（CVIB）减小；C组心肌的IBS％增高更明显；CVIB减小也更明显。且14支闭塞血管支配区域心肌的CVIB曲线与正常节段呈反向，N－delay在B组及C组明显延长，同一参数组间比较差异均有显著性（P＜0．01），结论：AD技术能客观反映正常，狭窄及闭塞冠状动脉脉供血区域心域心肌的不同组织特性变化，对鉴别冠心病不同病变心肌的灌流特征具有一定的诊断意义。     

左室室壁瘤造影诊断分析

目的探讨室壁瘤形成与冠状动脉粥样硬化的关系，以及室壁瘤对心室功能的影响。方法采用冠状动脉造影方法对168例临床疑诊冠心病患者进行检查。结果发现室壁瘤26例，其中冠状动脉单支病变11例，双支7例，三支7例，冠状动脉正常1例，受累血管狭窄程度均在III级以上。室壁瘤累及心室壁一段、二段、三段及四段的左室射血分数分别平均为(50±31)％、(32±16)％、(29±21)％及(18±14)％(r=-0.65，P     

阿托伐他汀干预对急性冠状动脉综合征患者PCI术后粘附分子水平的影响

Objective To explore the impact of different dose atorvastatin on the adhesion molecules level in the acute coronary syndrome (ACS) patients who had received percutaneous coronary intervention (PCI). Methods Eighty-eight ACS patients were divided into three groups, group A (normal treatment group), group B (normal treatment plus atorvastatin 10mg per day) and group C (normal treatment plus atorvastatin 80mg per day). The patients in group B received atorvastatin 10 mg per day orally before PCI and after PCI subsequently, and the patients in group C received atorvastatin 80 mg per day orally before PCI and after PCI subsequently for three days, then the dose of atorvastatin was decrease to 10 mg per day. The concentrations of soluble intercellular adhesionmolecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) were detected before PCI and at the 3rd, 7th 14th day after PCI. Results At the 7th day, the concentrations of sICAM-1 and sVCAM-1 in group C were significantly lower than those in group B, which showed sICAM-1 (68.35±23.80) μg/L vs (131.45±29.12) μg/L and sVCAM-1 (251. 65±36.61)μg/L vs (334.87±32.98) μg/L, respectively. Compared to group A, the adhesion molecule level in group B and group C were significantly decreased (P<0.05) and had no obviously affect on blood fat level. Conclusion The treatment of atorvastatin could significantly decrease the adhesion molecules' level after PCI, which may play an important role in lowing inflammation and coronary artery restenosis after PCI.     

阿托伐他汀干预对急性冠状动脉综合征患者PCI术后粘附分子水平的影响

Objective To explore the impact of different dose atorvastatin on the adhesion molecules level in the acute coronary syndrome (ACS) patients who had received percutaneous coronary intervention (PCI). Methods Eighty-eight ACS patients were divided into three groups, group A (normal treatment group), group B (normal treatment plus atorvastatin 10mg per day) and group C (normal treatment plus atorvastatin 80mg per day). The patients in group B received atorvastatin 10 mg per day orally before PCI and after PCI subsequently, and the patients in group C received atorvastatin 80 mg per day orally before PCI and after PCI subsequently for three days, then the dose of atorvastatin was decrease to 10 mg per day. The concentrations of soluble intercellular adhesionmolecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) were detected before PCI and at the 3rd, 7th 14th day after PCI. Results At the 7th day, the concentrations of sICAM-1 and sVCAM-1 in group C were significantly lower than those in group B, which showed sICAM-1 (68.35±23.80) μg/L vs (131.45±29.12) μg/L and sVCAM-1 (251. 65±36.61)μg/L vs (334.87±32.98) μg/L, respectively. Compared to group A, the adhesion molecule level in group B and group C were significantly decreased (P<0.05) and had no obviously affect on blood fat level. Conclusion The treatment of atorvastatin could significantly decrease the adhesion molecules' level after PCI, which may play an important role in lowing inflammation and coronary artery restenosis after PCI.